Biovail Files 2nd Suit To Protect Blood Pressure Drug
The new Biovail suit comes in response to an amended Abbreviated New Drug Application filed by Andrx for the drug blood pressure reducing drug Cardizem.
While the original ANDA only sought permission to produce 420 mg tablets of the drug, the amendment requests approval for 120, 180, 240, 300, and 360 mg. versions.
Biovail is seeking an injunction...
To view the full article, register now.